This advert is not available!
Umeå University is one of Sweden’s largest higher education institutions with over 37,000 students and about 4,700 employees. The University offers a diversity of high-quality education and world-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything is close. Our cohesive campuses make it easy to meet, work together and exchange knowledge, which promotes a dynamic and open culture.
The ongoing societal transformation and large green investments in northern Sweden create enormous opportunities and complex challenges. For Umeå University, conducting research about – and in the middle of – a society in transition is key. We also take pride in delivering education to enable regions to expand quickly and sustainably. In fact, the future is made here.
Are you interested in learning more? Read about Umeå university as a workplace
The Faculty of Medicine, which consists of 12 departments, is responsible for biomedical research and courses in the field of nursing and health care and has an extensive research and graduate education in more than 80 subjects.
Postdoctoral position
Umeå University, Faculty of Medicine
Umeå University is dedicated to providing creative environments for learning and work. We offer a wide variety of courses and programs, world leading research, and excellent innovation and collaboration opportunities. More than 4 000 employees and 30 000 students have already chosen Umeå University. We welcome your application!
The Faculty of Medicine, which consists of 13 departments, is responsible for biomedical research and courses in the field of nursing and health care and has an extensive research and graduate education in more than 80 subjects.
Postdoctoral position in Virology
The Department of Clinical Microbiology, Umeå University, is looking for a research associate (postdoc) on a 2 year position. The associate will be active in a research project aiming at elucidating the contribution of endothelial glycocalyx degradation to hemorrhagic fever with renal syndrome (HFRS) disease and pathogenesis caused by Puumala virus infection. The long term goal is to identify novel targets for intervention.
Research Topic
Puumala virus is an orthohantavirus, and endemic in Northern Sweden and Eurasia. The virus is transmitted to humans by inhalation of contaminated bank vole excreta. Puumala virus causes a mild viral hemorrhagic fever and the disease is characterized by fever, renal dysfunction, and capillary leakage with increased risk for thromboembolic complications. Endothelial cells constitute a major target for infection and are believed to be central to disease pathogenesis. In particular, we are interested in the contribution of the endothelial glycocalyx to cardiovascular complications during HFRS.
In this project, we will use both in vitro endothelial cell models and protein-protein interaction studies to identify factors that degrade the endothelial glycocalyx during HFRS. Furthermore, the role of the endothelial glycocalyx in vascular leakage and thrombosis will be studied using in vitro cell models.
Responsibilities
You will be responsible for carrying out research as part of the Fors Connolly laboratory.
You will:
Selection criteria
In the first place applicants who have completed a doctoral degree no more than three years before the application deadline are considered. If there are special reasons, an earlier doctoral degree could be considered. Special reasons refer to leave due to illness, parental leave or clinical service, trust assignments within trade union organizations or other similar circumstances”.
The successful candidate should have a PhD in medical or natural sciences with focus on infection biology, cell biology, or related disciplines.
Expertise both in virology and in cell biology with particular focus on the endothelial glycocalyx would be a strong asset. Experience with transwell permeability assays, immunofluorescence, isolating PBMCs, handling platelets, endothelial cell culture, handling viruses in a BSL-2 environment, and ELISAs are necessary requirements for this postdoc.
Ability to independently plan experiments, develop methods and carry out analyzes, and summarize results in English is a requirement.
It is expected that the candidate can conduct research in a highly independent manner. In addition, the candidate should have documented good ability to work in an interdisciplinary environment at the interface between medicine and biology and to cooperate with other research groups.
Research environment
This postdoc project will be carried out in a highly interdisciplinary environment. The fellow will be active in the young group of Anne-Marie Fors Connolly at the Department of Clinical Microbiology. Her group focuses on cardiovascular complications following HFRS from molecular interactions to population-based epidemiological studies. In particular, a main focus is on the contribution of endothelial cells to HFRS pathogenesis. The fellow will further work in close collaboration with the groups of Marta Bally (Department of Clinical Microbiology, Virology) and Clas Ahlm (Department of Clinical Microbiology, Infectious Diseases).
Position summary
Full time position, two years – start according to agreement.
Application
The application should contain:
The application is made electronically (via the system Varbi).
Last day to apply is: March 19, 2020
For questions, please contact:
Anne-Marie Fors Connolly, Department of Clinical Microbiology,
E-mail: anne-marie.fors.connolly@umu.se
We welcome your application!
Type of employment | Temporary position |
---|---|
Contract type | Full time |
First day of employment | Enligt överenskommelse |
Salary | Månadslön |
Number of positions | 1 |
Full-time equivalent | 100 % |
City | Umeå |
County | Västerbottens län |
Country | Sweden |
Reference number | AN 2.2.1-1733-19 |
Contact |
|
Union representative |
|
Published | 11.Nov.2019 |
Last application date | 21.Jan.2020 11:59 PM CET |